aTyr Pharma (LIFE)
1.60
-0.02 (1.23%)
Upcoming Events
Latest Headlines
Form ARS aTYR PHARMA INC For: Dec 31
April 5, 2024 4:04 PM - SEC Filing
Form DEFA14A aTYR PHARMA INC
April 5, 2024 4:02 PM - SEC Filing
Form DEF 14A aTYR PHARMA INC For: May 22
April 5, 2024 4:01 PM - SEC Filing
aTyr Pharma to Participate in April Investor Conferences
April 1, 2024 8:00 AM - StreetInsider
Form 8-K Xenetic Biosciences, For: Mar 22
March 22, 2024 8:00 AM - SEC Filing
Form 10-K Xenetic Biosciences, For: Dec 31
March 21, 2024 5:03 PM - SEC Filing
Form SC 13D/A Xenetic Biosciences, Filed by: CLS Therapeutics, LLC
March 18, 2024 1:45 PM - SEC Filing
aTyr Pharma (LIFE) PT Lowered to $16 at RBC Capital
March 15, 2024 6:39 AM - StreetInsider
Form 10-K aTYR PHARMA INC For: Dec 31
March 14, 2024 4:39 PM - SEC Filing
aTyr Pharma (LIFE) Misses Q4 EPS by 1c
March 14, 2024 4:14 PM - StreetInsider
Form 8-K aTYR PHARMA INC For: Mar 14
March 14, 2024 4:02 PM - SEC Filing
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024 4:00 PM - StreetInsider
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
February 28, 2024 8:00 AM - StreetInsider
aTyr Pharma (LIFE) Announces Expanded Access Program (EAP) for EFZO-FIT Clinical Trial Participants
February 21, 2024 8:03 AM - StreetInsider
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
February 21, 2024 8:00 AM - StreetInsider
Form SC 13G/A aTYR PHARMA INC Filed by: LYTTON LAURENCE W
February 14, 2024 1:44 PM - SEC Filing
Form SC 13G/A aTYR PHARMA INC Filed by: Stonepine Capital Management, LLC
February 13, 2024 4:31 PM - SEC Filing
Form 8-K Xenetic Biosciences, For: Feb 12
February 12, 2024 9:15 AM - SEC Filing
Form SC 13G/A aTYR PHARMA INC Filed by: FMR LLC
February 9, 2024 8:36 AM - SEC Filing
Form 4 aTYR PHARMA INC For: Feb 05 Filed by: Shukla Sanjay
February 6, 2024 8:21 PM - SEC Filing
Form 4 aTYR PHARMA INC For: Feb 05 Filed by: Broadfoot Jill Marie
February 6, 2024 8:19 PM - SEC Filing
Form 4 aTYR PHARMA INC For: Feb 05 Filed by: DENYES NANCY
February 6, 2024 8:16 PM - SEC Filing
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024 8:00 AM - StreetInsider
Full Article List
